Cargando…

Corrigendum: Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634081/ https://www.ncbi.nlm.nih.gov/pubmed/28937037 http://dx.doi.org/10.4103/0366-6999.215346

Ejemplares similares

Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System
Publicado: (2017)

Central nervous system tumefactive demyelinating lesions: Risk factors of relapse and follow-up observations
por: Li, Xinnan, et al.
Publicado: (2022)

Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma
por: Sun, Chenjing, et al.
Publicado: (2022)

Recurrent tumefactive demyelinating lesions in an elderly woman
por: Weil, Erika L., et al.
Publicado: (2022)

Pitfalls in the diagnosis of a tumefactive demyelinating lesion: A case report
por: Gavra, Maria, et al.
Publicado: (2011)

Silent Tumefactive Demyelinating Lesions and Radiologically Isolated Syndrome
por: Ekmekci, Ozgul, et al.
Publicado: (2018)

Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments
por: Brod, Staley A, et al.
Publicado: (2019)

Corrigendum: Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective
Publicado: (2023)

Progression of tumefactive demyelinating lesion in a child demonstrated with MRI
por: De Simone, Marta, et al.
Publicado: (2017)

AZD-1222: Tumefactive demyelinating brain lesion : case report
Publicado: (2022)

Recurrent tumefactive demyelination: An unusual presentation
por: Bhargava, Amita, et al.
Publicado: (2015)

Neuroimaging features of tumefactive demyelinating lesions: A rare case report
por: Febyan, et al.
Publicado: (2020)

Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases
por: Vakrakou, Aigli G., et al.
Publicado: (2022)

Clinical spectrum and prognosis of pathologically confirmed atypical tumefactive demyelinating lesions
por: Zhang, Yajing, et al.
Publicado: (2023)

Corrigendum to: “2019 guidelines for the diagnosis and management of chronic coronary syndromes”: congratulations and tribulations
Publicado: (2021)

Corrigendum: In vivo astrocyte-to-neuron reprogramming for central nervous system regeneration: a narrative review
Publicado: (2023)

A Case of Relapsing-Remitting Tumefactive Demyelination
por: Wadhwa, Ankur, et al.
Publicado: (2019)

Isolated Medullary Tumefactive Demyelination Masquerading as Tumor
por: Manoj,, et al.
Publicado: (2022)

Corrigendum to “Evaluation of Novel Stereotactic Cannula for Stem Cell Transplantation against Central Nervous System Disease”
por: Kawabori, Masahito, et al.
Publicado: (2021)

Tumefactive demyelinating disease with isolated spinal cord involvement
por: Makary, Mina S, et al.
Publicado: (2014)

Case Report: Paraneoplastic Tumefactive Demyelination Associated With Seminoma
por: Shiraishi, Wataru, et al.
Publicado: (2022)

Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system
por: Gonzalez, Ginez A., et al.
Publicado: (2016)

Russian guidelines for the management of COPD: algorithm of pharmacologic treatment [Corrigendum]
Publicado: (2019)

Successful treatment of HIV-associated tumefactive demyelinating lesions with corticosteroids and cyclophosphamide: a case report
por: Lazzarin, Serena Marita, et al.
Publicado: (2020)

Tumefactive demyelinating CNS lesion in a 60-year-old woman with familial Mediterranean fever
por: Trostel, Constanze, et al.
Publicado: (2021)

Phenotyping variants of tumefactive demyelinating lesions according to clinical and radiological features—A case series
por: Boyle, Thérèse, et al.
Publicado: (2023)

Corrigendum to “A Patient with Double-Negative VGKC, Peripheral Nerve Hyperexcitability, and Central Nervous System Symptoms: A Postinfectious Autoimmune Disease”
por: Eikeland, Birte
Publicado: (2020)

Tumefactive demyelination following herbal supplement use: Cause or coincidence?
por: Dubey, D, et al.
Publicado: (2016)

Tumefactive demyelination in a patient with relapsing-remitting MS on ocrelizumab
por: Moreira Ferreira, Vanessa F., et al.
Publicado: (2019)

Tumefactive Demyelination—A Rare Presentation of Anti-MOG Syndrome
por: Sivadasan, Sesh, et al.
Publicado: (2022)

Tumefactive Demyelination versus Primary Central Nervous System Lymphoma on (18)F-Fluorodeoxyglucose Positron Emission Tomography Magnetic Resonance Imaging: A Twist in the Tale
por: Biswas, Shamick, et al.
Publicado: (2019)

Corrigendum to “A Systematic Review of Peripheral and Central Nervous System Involvement of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Primary Sjögren's Syndrome, and Associated Immunological Profiles”
por: Bougea, Anastasia, et al.
Publicado: (2016)

Commentary: Tumefactive Demyelinating Lesions as a First Clinical Event: Clinical, Imaging, and Follow-up Observations
por: Koudriavtseva, Tatiana, et al.
Publicado: (2016)

Deep Learning With Data Enhancement for the Differentiation of Solitary and Multiple Cerebral Glioblastoma, Lymphoma, and Tumefactive Demyelinating Lesion
por: Zhang, Yu, et al.
Publicado: (2021)

Corrigendum: 2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea
por: Seo, Mi Hae, et al.
Publicado: (2019)

Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma [Corrigendum]
Publicado: (2023)

Demyelinating Disorders of the Central Nervous System
por: Pirko, Istvan, et al.
Publicado: (2007)

Corrigendum to “Recommendations for Diagnosis and Management of Osteoporosis in COPD Men”
por: Mazokopakis, Elias E., et al.
Publicado: (2017)

Tumefactive multiple sclerosis masquerade as a central nervous system tumor: a case report
por: Turkistani, Alaa Nabil, et al.
Publicado: (2018)

Guideline development for the management of gout: role of combination therapy with a focus on lesinurad [Corrigendum]
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e6rcnru66u9gus7l70ps1n9bkn